Comparative Oral Bioavailability
Comparative Oral Bioavailability is a pharmacokinetic metric that quantifies and contrasts the systemic availability of a drug following oral administration across different species, normalizing for dose and accounting for interspecies differences in absorption, metabolism, and elimination.
261
Publications
9.8K
Citations
1.2K
Authors
415
Institutions
Publications per year
2017–2026
32
261
Jan Philipp Schuchardt, Inga Schneider, H.‐D. Meyer et al. · Lipids in Health and Disease · 2011 · 285 citations · Full text
1–5 of 261
1.2K
5
h-index
4
h-index
4
h-index
4
h-index
3
h-index
1–5 of 1.2K
415
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
7 h-index
28 publications
430 citations
Novartis (Switzerland)
Basel, Switzerland
5 h-index
13 publications
1.3K citations

Ghent University
Ghent, Belgium
5 h-index
32 publications
2K citations

Universidade Estadual de Campinas (UNICAMP)
Campinas, Brazil
5 h-index
10 publications
155 citations
National Institute of Pharmaceutical Education and Research
Mohali, India
4 h-index
14 publications
576 citations
Pfizer (United States)
New York, United States
4 h-index
17 publications
1.8K citations
National Research Centre
Giza, Egypt
4 h-index
11 publications
272 citations
United States Military Academy
West Point, United States
4 h-index
12 publications
886 citations
1–8 of 415
Repository · 23 publications · 609 citations
14
h-index
12 publications · 607 citations
12
h-index
14 publications · 207 citations
11
h-index
10 publications · 191 citations
10
h-index
10 publications · 592 citations
10
h-index
1–5